Skip to main content
Log in

Adverse events associated with transoral incisionless fundoplication (TIF) for chronic gastroesophageal reflux disease: a MAUDE database analysis

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Transoral incisionless fundoplication (TIF) has been used for treating chronic gastroesophageal reflux disease (GERD) refractory to medical therapy. We aim to investigate the complications associated with TIF using a national database.

Methods

We analyzed post-marketing surveillance data from the FDA Manufacturer and User Facility Device Experience (MAUDE) database from Jan 2011 through Jan 2021.

Results

During the study period, approximately 95 event cases reported to the FDA. Approximately 131 patient complications were identified. The number of adverse events declined from 2011 to 2016 (R2 = 0.96) but increased from 2016 to 2020 (R2 = 0.99). The most common adverse event was perforation (19.8%), followed by laceration 17.6%, bleeding (9.2%), and pleural effusion (9.2%). The most common patient complications were treated using endoscopic clips (12.3%), chest tube or drain insertion (12.3%), use of endoscopic retriever device (11.1%), esophageal stent (8.6%), and emergent or open surgery (11.1%).

Conclusions

Adverse events from TIF range from mild to severe. Further research is needed to develop approaches aimed at reducing patient risks.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yamasaki T, Hemond C, Eisa M, Ganocy S, Fass R (2018) The changing epidemiology of gastroesophageal reflux disease: are patients getting younger? J Neurogastroenterol Motil 24:559–569

    Article  Google Scholar 

  2. Trad KS, Turgeon DG, Deljkich E (2012) Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms. Surg Endosc 26:650–660

    Article  Google Scholar 

  3. Witteman B, Conchillo J, Rinsma N et al (2015) Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol 110:531–542

    Article  CAS  Google Scholar 

  4. Triadafilopoulos G, Clarke JO, Hawn M (2017) Precision GERD management for the 21st century. Dis Esoph 30:1–6

    Google Scholar 

  5. Frazzoni M, Piccoli M, Conigliaro R, Frazzoni L, Melotti G (2014) Laparoscopic fundoplication for gastroesophageal reflux disease. World J Gastroenterol 20:14272–14279

    Article  Google Scholar 

  6. Cadière GB, Buset M, Muls V et al (2008) Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg 32:1676–1688

    Article  Google Scholar 

  7. Testoni PA, Testoni S, Distefano G, Mazzoleni G, Fanti L, Passaretti S (2019) Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years. Endosc Int Open 7:E647–E654

    Article  Google Scholar 

  8. Huang X, Chen S, Zhao H et al (2017) Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis. Surg Endosc 31:1032–1044

    Article  Google Scholar 

  9. Chang K, Bell R (2020) Transoral incisionless fundoplication. Gastrointest Endosc Clin N Am 30:267–289

    Article  Google Scholar 

  10. Hoppo T, Immanuel A, Schuchert M et al (2010) Transoral incisionless fundoplication 2.0 procedure using EsophyXTM for gastroesophageal reflux disease. J Gastrointest Surg 14:1895–1901

    Article  Google Scholar 

  11. Agostoni M, Boemo C (2010) Bilateral pneumothorax during transoral incisionless fundoplication. Eur J Anaesthesiol 27:216–217

    Article  Google Scholar 

  12. Narsule CK, Burch MA, Ebright MI et al (2012) Endoscopic fundoplication for the treatment of gastroesophageal reflux disease: initial experience. J Thorac Cardiovasc Surg 143:228–234

    Article  CAS  Google Scholar 

  13. Muls V, Eckardt AJ, Marchese M et al (2013) Three-year results of a multicenter prospective study of transoral incisionless fundoplication. Surg Innov 20:321–330

    Article  Google Scholar 

  14. Stefanidis G, Viazis N, Kotsikoros N et al (2017) Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy. Dis Esophagus 30:1–8

    PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Douglas G. Adler.

Ethics declarations

Disclosures

Drs. Daryl Ramai, Alexandra Shapiro, Mohamed Barakat, Antonio Facciorusso, Adriane Dull, Saurabh Chandan, and Douglas G. Adler have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ramai, D., Shapiro, A., Barakat, M. et al. Adverse events associated with transoral incisionless fundoplication (TIF) for chronic gastroesophageal reflux disease: a MAUDE database analysis. Surg Endosc 36, 4956–4959 (2022). https://doi.org/10.1007/s00464-021-08851-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-021-08851-x

Keywords

Navigation